 Effects recombinant human erythropoietin plasma levels vasoactive regulatory peptides patients maintenance hemodialysis plasma levels vasoactive regulatory peptides radioimmunoassay stable patients chronic renal failure regular hemodialysis treatment recombinant human erythropoietin r-huEPO patients significant increases hemoglobin concentrations hematocrit Mean arterial blood pressure changes body weight interdialytic body gain mean plasma levels atrial natriuretic peptide motilin percent r-huEPO treatment changes mean plasma levels arginine vasopressin calcitonin gene-related peptide beta-lipotropin gamma hormone substance vasoactive intestinal peptide significant correlations changes plasma peptide levels changes mean arterial blood pressure